Eli Lilly just launched a new program to make GLP‑1 weight‑loss drugs cheaper for millions of workers

The new platform lets employers offer GLP-1 drugs like Zepbound at a discounted rate while choosing from a marketplace of administrators.
Indianapolis Business Journal

Lilly introduces direct-to-employer program for weight-loss drug

Eli Lilly and Co. has launched a platform that offers employers coverage options for obesity care through a partnership with 18 digital health programs.
MobiHealthNews

Noom launches microdose GLP-1 weight loss program

Diet weight loss company Noom announced it is launching a new program dubbed the Noom Microdose GLP-1Rx Program, which will provide members with personalized microdoses of GLP-1 medication. The ...
Nasdaq

Omada Health's GLP-1 Companion Program Enhances Medication Persistence and Weight Loss Outcomes

Omada Health has released new data indicating that its GLP-1 companion program significantly enhances medication persistence for GLP-1 treatments, which are linked to increased weight loss. The ...
Provider Magazine

Setting Up Systems to Prevent Weight Loss

Weight loss is rarely about one missed tray. It usually reflects breakdowns in workflow, observation, communication, and ...